13 Stocks Are Members of the $1 Trillion Club. Here's the Best Pick to Buy Right Now. Want to really go big? One megacap stock offers an especially attractive risk-reward proposition.
Novo Nordisk's Wegovy Pill Just Hit 3 Million Prescriptions. Is Wall Street Missing Something With This Beaten-Down Stock? Novo Nordisk has been telling investors that volume will eventually offset price cuts, and early results suggest investors should listen.
3 Penny Stocks Under $5 Backed by Real Revenue Growth These three penny stocks under $5 generate real revenue and have catalysts that analysts believe could drive significant upside
3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend With GLP-1 usage continuing to rise, a group of unlikely beneficiaries is emerging; stocks in the broader health care sector and even in retail could stand out.
3 Reasons to Buy Eli Lilly Stock Despite several setbacks over the past year, the drugmaker marches on.
Here’s How Much You Would Have Made Owning Eli Lilly Stock In The Last 15 Years Eli Lilly (
NYSE:LLY ) has outperformed the market over the past 15 years by 12.92% on an annualized basis producing an average annual ...
Market-Weighted Healthcare or Active Manager Selection? IYH vs. PINK The iShares U.S. Healthcare ETF (IYH) tracks a broad healthcare index, while the Simplify Health Care ETF (PINK) gives an active manager more room to choose. That difference matters for investors deciding whether they want benchmark exposure or a more concentrated healthcare portfolio.
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought After a few days of purging, the Ark Invest growth investor is buying stocks again.
3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound Led by Eli Lilly’s GLP-1 success, Humana’s expanding margins, and DexCom’s medtech growth, the healthcare sector is staging a major market rebound.
Vanguard (VHT) vs VanEck (PPH): Which Healthcare ETF Is the Better Buy? Broader diversification or higher yield? Explore how these two healthcare ETFs stack up for different investor goals.
Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors? Compare risk profiles, sector concentration, and income potential as these two healthcare ETFs take different approaches to growth and stability.
3 Underrated Dividend Stocks That Could Generate Reliable Cash Flow for Your Portfolio for Decades These stocks may not be your first choices when looking for dividends, but they have been income-generating machines for years.
Eli Lilly vs. Novo Nordisk: Better Obesity Drug Stock? These two healthcare leaders have a long history of competing against one another.
Health Care ETFs: XLV Delivers Low Fees and Solid Returns Explore how portfolio concentration and stock count set these healthcare ETFs apart, impacting risk and diversification for investors seeking sector exposure.
FHLC vs. IYH: Which Healthcare ETF Is the Better Buy in 2026? Portfolio size and stock selection set these healthcare ETFs apart and help shape their risk and return profiles.
3 Under-the-Radar Stocks to Buy and Hold for a Decade All three could become highly prominent biotech companies within 10 years.
1 Profitable Stock to Target This Week and 2 We Avoid Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...
